Phase 3

Phase 3 clinical trials administer the experimental medicine or treatment to large groups of people (1,000–3,000) to further confirm its effectiveness, monitor side effects, and/or compare it with standard or equivalent treatments. If a medicine successfully passes a Phase 3 clinical trial, it can be approved by the Food and Drug Administration for public sale and use.